Quick Answer: Jeuveau vs Botox Key Differences
Jeuveau and Botox are both FDA-approved neurotoxins containing botulinum toxin type A that temporarily relax facial muscles to reduce wrinkles. Jeuveau received FDA approval in February 2019 as the first aesthetic-only neurotoxin, specifically developed for cosmetic use rather than medical conditions.
Here's what you need to know about Jeuveau vs Botox:
FDA approvals:
- Jeuveau: Only approved for frown lines (glabellar lines) between the eyebrows
- Botox: Approved for frown lines, forehead lines, crow's feet, plus multiple medical conditions
Development focus:
- Jeuveau: Created exclusively for cosmetic purposes using Hi-Pure technology
- Botox: Has both cosmetic and medical therapeutic uses
Duration: Jeuveau: Typically 3-4 months, some patients report up to 5 months. Botox: Typically 3-4 months.
Cost: Both typically priced at $10-$20 per unit. Jeuveau was initially marketed as 20-30% cheaper but prices are now comparable.
Onset: Jeuveau: Some patients see results within 2-3 days. Botox: Usually visible within 3-5 days.
Both products work identically to relax facial muscles and produce similar cosmetic results for most patients.
Understanding Jeuveau: The "Newtox"
Before comparing specific differences, it helps to understand what Jeuveau is and how it entered the market.
What Is Jeuveau?
Jeuveau (prabotulinumtoxinA-xvfs) is a botulinum toxin type A product manufactured by Evolus in South Korea. It's a 900 kDa purified formulation developed specifically for aesthetic use, making it unique among neurotoxins.
The product is sometimes called "Newtox" (a play on "new Botox") because it's the first new neurotoxin to receive FDA approval in nearly a decade. Jeuveau entered the market specifically targeting the cosmetic neurotoxin space rather than serving dual cosmetic and medical purposes.
Hi-Pure Technology
Jeuveau is manufactured using what Evolus calls "Hi-Pure technology," a proprietary purification process designed to remove certain proteins from the final formulation. The manufacturer claims this purification method may contribute to faster absorption and potentially quicker onset of results, though individual experiences vary.
The product is manufactured in a state-of-the-art facility built specifically for Jeuveau production, maintaining strict quality and safety standards.
Clinical Development
Jeuveau's FDA approval was supported by the TRANSPARENCY clinical program, which studied over 2,100 patients globally. This included two Phase III U.S. placebo-controlled trials and a European and Canadian Phase III head-to-head trial versus Botox. Importantly, there were no serious drug-related adverse events reported in these studies.
FDA Approvals: A Key Difference
The range of approved uses represents one of the most significant differences between these products.
Jeuveau's Limited Approval
Jeuveau is currently FDA-approved only for temporarily improving the appearance of moderate to severe glabellar lines (frown lines between the eyebrows) in adults. This single cosmetic indication reflects its development as an aesthetic-only product.
Any use of Jeuveau outside of treating frown lines is considered "off-label," though providers commonly use it for other facial areas like forehead lines, crow's feet, and other wrinkles. Off-label use is legal and common in medicine when providers determine it's safe and beneficial.
Botox's Multiple Approvals
Botox has significantly broader FDA approval for both cosmetic and medical conditions:
Cosmetic approvals:
- Frown lines (glabellar lines)
- Horizontal forehead lines
- Crow's feet around the eyes
Medical approvals:
- Chronic migraines
- TMJ and jaw clenching
- Excessive sweating (hyperhidrosis)
- Overactive bladder
- Cervical dystonia
- Blepharospasm (eyelid spasms)
- Strabismus (eye muscle disorders)
This broader approval range means Botox serves dual purposes that Jeuveau cannot. If you're seeking treatment for a medical condition, Botox is your only option between these two products.
Jeuveau vs Botox Results: What to Expect
The most important consideration is whether they produce similar cosmetic outcomes.
Effectiveness Comparison
Clinical trials and real-world experience demonstrate that Jeuveau and Botox are equally effective for treating frown lines. Both neurotoxins work by blocking acetylcholine release, which prevents muscle contractions and smooths wrinkles. Both products:
- Reduce wrinkle depth and severity
- Relax targeted facial muscles
- Create smoother, refreshed appearances
- Produce natural-looking results when properly administered
The clinical trial comparing Jeuveau directly to Botox showed equivalent efficacy, with both meeting all primary and secondary endpoints for wrinkle reduction.
Results Timeline
Onset of effects: Jeuveau: Many patients notice initial changes within 2-3 days, though it can take up to a week. Botox: Typically visible within 3-5 days for most people.
Full results: Both: Maximum effect appears at 10-14 days post-treatment.
Duration: Jeuveau: Averages 3-4 months, with some patients reporting effects lasting up to 5 months. Botox: Typically 3-4 months, though how long Botox lasts varies by individual.
The claimed faster onset with Jeuveau is anecdotal and not consistently demonstrated across all patients. Individual metabolism, muscle strength, and injection technique influence both onset and duration more than the specific product used.
Treatment Areas
For frown lines specifically (Jeuveau's approved use), both products perform identically. When used off-label for other areas:
Forehead lines: Both smooth horizontal forehead wrinkles effectively.
Crow's feet: Both reduce fine lines around the eyes.
Brow lift: Strategic placement with either can lift the brows.
Lip flip: Both relax the upper lip muscle for subtle enhancement.
Providers report no practical difference in how these products perform across various facial areas when used off-label.
Jeuveau vs Botox Cost Comparison
Understanding pricing helps with budgeting and value assessment.
Initial Pricing Expectations
When Jeuveau first launched, there was significant buzz that it would be 20-30% cheaper than Botox, making it a budget-friendly alternative. However, real-world pricing hasn't consistently reflected this expectation.
Current Market Pricing
Both products typically cost:
- $10-$15 per unit: Smaller markets and competitive practices
- $12-$18 per unit: Average pricing in most locations
- $15-$20 per unit: Major metropolitan areas and premium providers
Some practices do price Jeuveau slightly lower ($1-3 less per unit), but many charge identical rates for both products. The price difference that does exist varies significantly by geographic location and individual practice pricing strategies.
Unit Requirements
Jeuveau and Botox require the same number of units for each treatment area, meaning your total cost depends primarily on the per-unit rate rather than which product you choose.
Frown lines (glabellar lines): Standard dosing: 20 units. Cost at $15/unit: $300 for either product.
Forehead + frown lines: Standard dosing: 40 units total. Cost at $15/unit: $600 for either product.
Full upper face (forehead, frown lines, crow's feet): Standard dosing: 64 units total. Cost at $15/unit: $960 for either product.
The cost of Botox or Jeuveau for annual maintenance (3-4 treatments per year) typically ranges from $900-$2,400+ depending on your treatment areas.
Manufacturer Savings Programs
Both manufacturers offer patient savings programs:
Allé (Botox): Earn points on treatments that can be redeemed for discounts on future Botox or other Allergan products.
Jeuvi Rewards (Jeuveau): Earn points on treatments for savings on future Jeuveau sessions.
These loyalty programs can provide modest savings over time if you're committed to regular treatments with one product.
Side Effects and Safety Profile
Both neurotoxins have similar safety profiles when administered properly.
Common Side Effects
The most frequently reported side effects are virtually identical:
- Injection site pain, swelling, or bruising
- Temporary headache
- Eyelid drooping (ptosis) if toxin migrates
- Eyebrow asymmetry from uneven dosing or placement
- Flu-like symptoms
In Jeuveau's clinical trials, headache was the most common side effect (affecting about 12% of patients), with eyelid drooping reported in approximately 2% of patients. These rates are comparable to Botox.
Gender-Specific Considerations
One study found that adult men experienced slightly higher rates of headaches and eyelid drooping with Jeuveau compared to Botox. However, this difference was small and may not represent a significant concern for most patients.
Serious Risks
Both products carry the same FDA boxed warning about potential spread of toxin effects beyond the injection site. While rare, this can cause: difficulty swallowing or breathing, generalized muscle weakness, vision problems, speech difficulties. These serious effects are extremely uncommon when products are used cosmetically by trained providers at appropriate doses.
Long-Term Safety
Botox has over 30 years of use in aesthetic medicine since FDA approval in 2002, providing extensive long-term safety data. Jeuveau, approved in 2019, has a shorter track record but has shown excellent safety in clinical trials and real-world use over the past several years.
Who Should Choose Jeuveau vs Botox
Neither product is universally "better," but certain factors might favor one over the other.
Consider Jeuveau If:
You're seeking cosmetic treatment only: If you only want wrinkle reduction without any medical uses, Jeuveau's aesthetic-focused approach might appeal to you.
You want to try something new: If you're curious about newer technology and Hi-Pure manufacturing, Jeuveau offers a modern alternative.
Your provider offers better pricing: If Jeuveau is genuinely less expensive at your chosen practice, it provides identical results at lower cost.
You prefer faster onset: If the anecdotal reports of quicker results (2-3 days vs. 3-5 days) matter to you, Jeuveau might be worth trying.
Consider Botox If:
You have medical conditions: If you need treatment for migraines, TMJ, excessive sweating, or other medical issues, Botox is your only FDA-approved option between these two.
You prefer established products: Botox's 20+ years on the market provide extensive safety and efficacy data that some people find reassuring.
You have a positive history: If you've used Botox successfully and know how you respond, there's no compelling reason to switch.
Your provider prefers it: Provider experience and comfort with a specific product often matters more than minor theoretical differences between formulations.
When Either Works Equally Well
For most first-time patients seeking cosmetic treatment of frown lines, either product will produce excellent results. The choice often comes down to: provider availability and preference; price differences at your chosen practice; personal comfort with newer vs. established products; marketing appeal or brand perception.
Comparing to Other Neurotoxins
Jeuveau and Botox aren't your only options for wrinkle reduction. Neurotoxin injections including Botox, Dysport, Xeomin, Jeuveau, and Daxxify totaled nearly 9.5 million procedures in 2023, showing the widespread popularity of these treatments.
Dysport
Dysport uses a different protein formulation that spreads more than Botox or Jeuveau, which can be advantageous for larger treatment areas. It uses different unit dosing (typically 2.5-3 units of Dysport equal 1 unit of Botox), so direct price comparisons can be tricky.
Xeomin
Xeomin is a "naked" neurotoxin containing only pure botulinum toxin A without accessory proteins. This formulation theoretically reduces antibody formation risk for long-term users. Like Jeuveau and Botox, it uses 1:1 unit conversion.
Daxxify
The newest FDA-approved neurotoxin, Daxxify, claims to last up to 6 months (double the typical duration). It's more expensive per treatment but could be cost-effective if you need fewer annual sessions.
Each neurotoxin has unique characteristics, and your provider can help you understand which might work best for your specific goals.
Questions to Ask Your Provider
When deciding between Jeuveau and Botox, have a thorough conversation with your injector.
Essential questions include:
- Which product do you use more frequently, and why?
- Have you noticed any differences in results between Jeuveau and Botox?
- Is there a price difference between the two at your practice?
- Do you have experience with patients who've tried both products?
- Based on my goals, which would you recommend?
- Can I switch products if I'm not satisfied?
- What happens if I experience side effects?
- Do you include a follow-up visit to assess results?
Your provider's experience and skill with a particular product often matters more than subtle formulation differences.
Making Your Decision
Jeuveau and Botox are both effective, FDA-approved neurotoxins that temporarily relax facial muscles to reduce wrinkles. For treating frown lines specifically, clinical trials show they produce equivalent results with similar safety profiles.
The main differences are that Botox has broader FDA approval covering multiple cosmetic areas and medical conditions, while Jeuveau is approved only for frown lines and developed exclusively for aesthetic use. Jeuveau was marketed as a more affordable option, though real-world pricing is now comparable to Botox at most practices.
For cosmetic treatment of frown lines, either product works beautifully. Your choice might depend on whether you value Botox's established track record or Jeuveau's modern, aesthetic-focused approach. If you need treatment for medical conditions, Botox is your only option between these two.
The most important factor isn't which brand you choose, but rather finding an experienced injector who understands facial anatomy and can deliver natural-looking results with whichever neurotoxin they're using.